ScienceUnited States1 sourcesNeutral

STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making false and misleading claims about a cancer treatment.

ed silverman

via Stat

March 24, 2026 | 3:59 PM UTCUpdated 1h ago

Share Read original

Read the full article at Stat →

STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Stat

NewsDataUS

Comments

0 comments

Be respectful and constructive.

Loading comments...

STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

Source Verification

Comments

Ex-NFL QB explains why Ty Simpson is better than Fernando Mendoza

Green-synthesized N-acetylcarnosine-loaded gold nanoparticles as a novel ocular nanocarrier for antioxidant therapy and cataract prevention

Related Articles

This pinot noir hasn’t changed in 500 years

Gilead pens dual-purpose $2B Ouro M&A deal with Galapagos

China’s pharma rise rattles US policymakers